These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25851116)

  • 1. Why should governments invest in antibiotic drug discovery against multi-drug-resistant bacteria?
    Meletis G
    Recent Pat Antiinfect Drug Discov; 2014; 9(2):150. PubMed ID: 25851116
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of funding could undermine UK antibiotic resistance strategy, say experts.
    O'Dowd A
    BMJ; 2013 Dec; 347():f7618. PubMed ID: 24355390
    [No Abstract]   [Full Text] [Related]  

  • 3. The new $1 billion program created by the U.S. Patient Protection and Affordable Care Act to award federal subsidies to qualifying therapeutic discovery projects. Interview by Annalisa VanHook.
    Boegh V; Hecimovich GL
    Sci Transl Med; 2010 Jun; 2(38):38pc4. PubMed ID: 20608289
    [No Abstract]   [Full Text] [Related]  

  • 4. The drug-resistant bacteria that pose the greatest health threats.
    Willyard C
    Nature; 2017 Feb; 543(7643):15. PubMed ID: 28252092
    [No Abstract]   [Full Text] [Related]  

  • 5. Budget cuts and the plight of postdocs.
    Goozner M
    J Natl Cancer Inst; 2013 Feb; 105(3):153-4. PubMed ID: 23334223
    [No Abstract]   [Full Text] [Related]  

  • 6. Overcoming the current deadlock in antibiotic research.
    Schäberle TF; Hack IM
    Trends Microbiol; 2014 Apr; 22(4):165-7. PubMed ID: 24698433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The economics of resistant pathogens and antibiotic innovation.
    McKellar MR; Chernew ME; Fendrick AM
    Am J Manag Care; 2014 Mar; 20(3):193-7. PubMed ID: 24884749
    [No Abstract]   [Full Text] [Related]  

  • 8. Combatting antimicrobial resistance globally.
    Sugden R; Kelly R; Davies S
    Nat Microbiol; 2016 Sep; 1(10):16187. PubMed ID: 27670123
    [No Abstract]   [Full Text] [Related]  

  • 9. Report urges controversial 'delinkage' to foster new antibiotics.
    Holmes D
    Nat Med; 2014 Apr; 20(4):320. PubMed ID: 24710363
    [No Abstract]   [Full Text] [Related]  

  • 10. Improving antibiotic markets for long-term sustainability.
    Kesselheim AS; Outterson K
    Yale J Health Policy Law Ethics; 2011; 11(1):101-67. PubMed ID: 21381513
    [No Abstract]   [Full Text] [Related]  

  • 11. The toolbox is open, but who should pay for the job?
    Ladbury JE; Hall A; Skidmore J
    Nat Rev Drug Discov; 2014 Jul; 13(7):479-80. PubMed ID: 24981345
    [No Abstract]   [Full Text] [Related]  

  • 12. The $2.6 billion pill--methodologic and policy considerations.
    Avorn J
    N Engl J Med; 2015 May; 372(20):1877-9. PubMed ID: 25970049
    [No Abstract]   [Full Text] [Related]  

  • 13. Report calls for $2bn global fund to kickstart antibiotic development.
    Wise J
    BMJ; 2015 May; 350():h2635. PubMed ID: 25975228
    [No Abstract]   [Full Text] [Related]  

  • 14. Stimulating antibiotic development.
    Tillotson G
    Lancet Infect Dis; 2010 Jan; 10(1):2-3. PubMed ID: 20129141
    [No Abstract]   [Full Text] [Related]  

  • 15. [From the discovery of antibiotics to emerging highly drug-resistant bacteria].
    Meunier O
    Soins; 2015; (797):14-20. PubMed ID: 26154354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Public funding of clinical-stage antibiotic development in the United States and European Union.
    Eichberg MJ
    Health Secur; 2015; 13(3):156-65. PubMed ID: 26042859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in the Fight Against Multidrug-Resistant Bacteria 2005-2016: Modern Noninferiority Trial Designs Enable Antibiotic Development in Advance of Epidemic Bacterial Resistance.
    Rex JH; Talbot GH; Goldberger MJ; Eisenstein BI; Echols RM; Tomayko JF; Dudley MN; Dane A
    Clin Infect Dis; 2017 Jul; 65(1):141-146. PubMed ID: 29017263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Programs and Discoveries Aim to Combat Antibiotic Resistance.
    Hampton T
    JAMA; 2015 Jun 23-30; 313(24):2411-3. PubMed ID: 26039283
    [No Abstract]   [Full Text] [Related]  

  • 19. In the midst of the antimicrobial discovery conundrum: an overview.
    Tomaras AP; Dunman PM
    Curr Opin Microbiol; 2015 Oct; 27():103-7. PubMed ID: 26356257
    [No Abstract]   [Full Text] [Related]  

  • 20. Oncology pharmaceutical funding in New Zealand: a different approach and a proposal.
    Beatty PA; Laking GR
    J Oncol Pract; 2015 May; 11(3):249-51. PubMed ID: 25829524
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.